skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Recently, Informa Pharma Intelligence conduced an insightful webinar regarding the current market landscape and outlook for immuno-oncology, one of the fastest-growing and most complex markets for pharma.



PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology is a comprehensive look at the immuno-oncology landscape, and includes:

  • An overview of the current immuno-oncology market
  • Ongoing developments in the PD-1/PD-L1 therapy space
  • Challenges with PD-1/PD-L1 inhibitor development and treatment
  • An examination of:
    • Non-small cell lung cancer (NSCLC)
    • Bladder cancer
  • A look at the future of immuno-oncology

Watch webinar recording here







電話:+81 (0)3 6273 4260